No profile data available.
Emergent BioSolutions Inc. (EBS) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in Gaithersburg, United States, with about 900 full-time employees.
In Q3 2025 (the quarter ended September 30, 2025) revenue was $222.00 million. Its largest business segment, Mcm Products, brought in 61% of segment revenue in fiscal year 2025; United States was the largest region with 71%. Its market capitalization was $642.88 million as of December 4, 2025.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of December 4, 2025.
, a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States.
Mcm Products, with $456.70 million or 61% of segment revenue in fiscal year 2025. Next: Commercial Products (30%) and Other (8%).
United States: 71% of revenue by region in fiscal year 2025, followed by Other (18%).
$642.88 million as of December 4, 2025.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Jade Biosciences, Inc. (JBIO), Sana Biotechnology, Inc. (SANA), Prime Medicine, Inc. (PRME), Silence Therapeutics plc (SLN).